Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase

bococizumab 150 mg + rHuPH20 administered SC to healthy volunteers

bococizumab 300 mg administered SC to healthy volunteers

bococizumab 300 mg + rHuPH20 administered SC to healthy volunteers

bococizumab 450 mg + rHuPH20 administered SC to healthy volunteers

bococizumab 300 mg + rHuPH20 administered SC to subjects with hypercholesterolemia receiving a statin